Injectable dual-gelling cell-laden composite hydrogels for bone tissue engineering by Vo, T.N. et al.
Injectable Dual-Gelling Cell-Laden Composite Hydrogels for 
Bone Tissue Engineering
T.N. Voa, S.R. Shaha, S. Lua, A.M. Tataraa, E.J. Leea, T.T. Roha, Y. Tabatab, and A.G. 
Mikosa,c,*
aDepartment of Bioengineering, Rice University, P.O. Box 1892, MS 142, Houston, Texas, 
77251-1892, USA
bDepartment of Biomaterials, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, 
Japan
cDepartment of Chemical and Biomolecular Engineering, Rice University, P.O. Box 1892, MS 
362, Houston, Texas, 77251-1892, USA
Abstract
The present work investigated the osteogenic potential of injectable, dual thermally and 
chemically gelable composite hydrogels for mesenchymal stem cell (MSC) delivery in vitro and in 
vivo. Composite hydrogels comprising copolymer macromers of N-isopropylacrylamide were 
fabricated through the incorporation of gelatin microparticles (GMPs) as enzymatically digestible 
porogens and sites for cellular attachment. High and low polymer content hydrogels with and 
without GMP loading were shown to successfully encapsulate viable MSCs and maintain their 
survival over 28 days in vitro. GMP incorporation was also shown to modulate alkaline 
phosphatase production, but enhanced hydrogel mineralization along with higher polymer content 
even in the absence of cells. Moreover, the regenerative capacity of 2 mm thick hydrogels with 
GMPs only, MSCs only, or GMPs and MSCs was evaluated in vivo in an 8 mm rat critical size 
cranial defect for 4 and 12 weeks. GMP incorporation led to enhanced bony bridging and 
mineralization within the defect at each timepoint, and direct bone-implant contact as determined 
by microcomputed tomography and histological scoring, respectively. Encapsulation of both 
GMPs and MSCs enabled hydrogel degradation leading to significant tissue infiltration and 
osteoid formation. The results suggest that these injectable, dual-gelling cell-laden composite 
hydrogels can facilitate bone ingrowth and integration, warranting further investigation for bone 
tissue engineering.
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1. Introduction
The craniofacial bone provides the natural contouring of the face as well as mechanical 
support of the overlying tissues. Current treatments for craniofacial injury resulting from 
trauma, disease, or congenital defects rely on the use of bone grafts taken from the patient or 
a donor that require extensive reshaping and multiple invasive surgeries. Tissue engineering 
provides a strategy by which combinations of biomaterial scaffolds, cells and/or growth 
factors can be designed for minimally invasive aesthetic and functional reconstruction [1, 2]. 
Thus, injectable, in situ forming hydrogels are attractive candidates for craniofacial bone 
tissue engineering applications. These materials can be prepared as aqueous solutions at 
room temperature, allowing easy mixing of cells or growth factors, and administered 
minimally invasively via injection whereby the material can conform to and support the 
defect during regeneration.
We previously reported on the development and characterization of an injectable, in situ 
forming hydrogel system based on N-isopropylacrylamide (NiPAAm) [3, 4]. By 
copolymerizing NiPAAm with epoxy pendant rings and lactone moieties to form a 
thermogelling macromer (TGM), an injectable dual-gelling hydrogel system was created 
that could both thermally and chemically gel with a diamine-functionalized polyamidoamine 
(PAMAM) crosslinker, form in situ, and hydrolytically degrade over time. Previous work 
has demonstrated the hydrogel’s rapid and dual gelation without syneresis, tunable 
physiochemical properties, biocompatibility in vivo, and hydrophobicity-dependent 
mineralization [3, 4].
The objective of this work was to evaluate the osteogenic potential and regenerative capacity 
of an injectable dual-gelling hydrogel system for stem cell delivery in vitro and in vivo. 
Mesenchymal stem cells (MSCs) were chosen as the cell source due to their established 
multipotent differentiation potential, particularly down the osteogenic lineage, availability 
and ease of sourcing, and proliferative capacity in vitro [5]. Additionally, MSCs interact 
through paracrine signaling processes to modulate the behavior of host cells and the 
inflammatory response that may promote a favorable regenerative outcome [5]. In order to 
provide sites for cellular attachment within the synthetic hydrogel and enhance hydrolysis-
dependent degradation, gelatin microparticles (GMPs) were added as an enzymatically 
digestible porogen [6]. We hypothesized that viable MSC-laden hydrogels could be formed 
and that the hydrogels could modulate encapsulated cell viability, osteogenic differentiation, 
and hydrogel mineralization in vitro through TGM content and incorporation of GMPs. 
Additionally, when implanted in an 8 mm rat critical size cranial defect, the composite 
hydrogel constructs with both GMPs and MSCs were hypothesized to enhance bone 
regeneration, as assessed through microcomputed tomography (microCT) of bony bridging 
and bone volume, and improve tissue integration and infiltration, as evaluated through 
histological scoring, compared to hydrogels with either GMPs or MSCs alone.
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2. Materials and Methods
2.1 Materials
NiPAAm, dimethyl-γ-butyrolactone acrylate (DBA), glycidyl methacrylate (GMA), acrylic 
acid (AA), 2,2’-azobis(2-methylpropionitrile) (azobisisobutyronitrile, AIBN), N,N’-
methylenebisacrylamide (MBA), piperazine (PiP), glycine, and glutaraldehyde were 
purchased from Sigma Aldrich (Sigma, St. Louis, MO) and used as received. Anhydrous 
1,4-dioxane, diethyl ether, and acetone in analytical grade; and water, acetonitrile, 
chloroform, and methanol in HPLC-grade were purchased from VWR (Radnor, PA) and 
used as received. PBS (powder, pH 7.4) was obtained from Gibco Life, Grand Island, NY. 
Ultrapure water was obtained from a Millipore Super-Q water system (Millipore, Billerica, 
MA). Acidic gelatin (IEP=5.0) was obtained from Nitta Gelatin (Osaka, Japan). Complete 
osteogenic medium (COM) was made from minimal essential medium α modification 
(αMEM) (Gibco Life, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS) 
(Cambrex BioScience, Walkersville, MD), 10−8 M dexamethasone, 10 mM β-glycerol 2-
phosphate, 50 mg/L ascorbic acid, and 10 mL/L antibiotic-antimycotic solution (Gibco, Life, 
Grand Island, NY). Live/Dead viability/cytotoxicity kit was purchased from Molecular 
Probes (Eugene, OR). The calcium assay was purchased from Genzyme Diagnostics 
(Cambridge, MA).
2.2 TGM synthesis and characterization
Synthesis of P(NiPAAm-co-GMA-co-DBA-co-AA) TGMs were performed according to 
published protocols [4]. Briefly, 10 g of NiPAAm, GMA, DBA and AA were dissolved in 
200 mL of anhydrous 1,4-dioxane under nitrogen at 65°C. AIBN pre-dissolved in the 
solvent was added at 0.7% of total mol content of the comonomers to thermally initiate free 
radical polymerization, and the reaction mixture was stirred for 16 h. After solvent removal 
by rotary evaporation, the material was re-dissolved in pure acetone and purified twice via 
dropwise precipitation in at least 10X excess diethyl ether. The recovered polymer was air-
dried overnight and transferred to a vacuum oven for several days prior to elemental 
analysis. The chemical composition of the TGMs was determined by proton nuclear 
magnetic resonance spectroscopy (1H NMR, Bruker, Switzerland) in D2O at a concentration 
of 20 mg/mL that contained 0.75 wt% 3- (trimethylsilyl)propionic-2,2,3,3-d4 acid sodium 
salt as an internal shift reference (Sigma-Aldrich, St. Louis, MO). Acid titration was 
performed in conjunction with 1H NMR to determine the AA content of the TGMs before 
hydrolysis. Aqueous gel permeation chromatography using a Waters Alliance HPLC system 
(Milford, MA) and differential refractometer (Waters, model 410) equipped with a series of 
analytical columns (Waters Styragel guard column 20 mm, 4.6 x 30 mm; Waters 
Ultrahydrogel column 1000, 7.8 x 300 mm) was used to determine the molecular weight 
distributions of the synthesized TGM. The weight average molecular weight (Mw), number 
average molecular weight (Mn), and polydispersity index (PDI = Mw/Mn) of the hydrolyzed 
polymer were determined by comparison to commercially available narrowly dispersed 
molecular weight poly(ethylene glycol) standards (Waters, Mississauga, ON). For this study, 
P(NiPAAm85.6-co-GMA6.0-co-DBA5.5-co-AA2.9) with a Mn = 36.4 kDa and PDI of 3.8 
demonstrating 30% hydrolysis-dependent degradation over 10 weeks was used.
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2.3 PAMAM synthesis and characterization
PAMAM was synthesized by the polyaddition of PiP and MBA at a stoichiometric molar 
ratio of [MBA]/[PiP] = 0.75 or 0.83 following previously reported protocols [7]. Molecular 
weight distributions of the synthesized PAMAM crosslinkers were analyzed using time-of-
flight mass spectroscopy with positive-mode electrospray ionization on a Bruker microTOF 
ESI spectrometer (Bruker Daltonics, Billerica, MA) equipped with a 1200 series HPLC 
(Agilent Technologies, Santa Clara, CA) to deliver the mobile phase (50:50 HPLC-grade 
water and methanol). After data acquisition, all peaks (including degradation and secondary 
reaction products) were identified using microTOF Control software (Bruker). The peaks 
were corrected for charge state (generally with H+ or Na+ and rarely K+ ions), and 
quantified for calculation of Mn, Mw, and PDI. PAMAM with Mn = 1440 or 2600 Da and 
PDI = 1.38 or 1.31, respectively were used for composite hydrogel characterization. The 
shorter molecular weight PAMAM crosslinker (P-1440) at a 1:1 amine epoxy mol ratio was 
chosen for the remaining MSC encapsulation studies.
2.4 GMP synthesis
GMPs with 50–100 μm diameter were synthesized through a water-in-oil emulsion followed 
by crosslinking in 10 mM glutaraldehyde solution and quenching with glycine as previously 
described [8]. Following fabrication, the GMPs were vacuum filtered, flash frozen in liquid 
nitrogen, lyophilized, and sieved.
2.5 Composite fabrication and characterization
Composite hydrogels were fabricated by combining the TGM and PAMAM crosslinker that 
were prepared at twice the desired concentrations in sterile phosphate buffered saline (PBS) 
pH 7.4 at 4°C until dissolved. GMPs were partially swelled in PBS pH 7.4 for 15 h at 4°C 
prior to hydrogel encapsulation as performed previously [8] and transferred to the polymer 
mixture. The resulting solution was manually mixed in the glass vial and transferred to 6 
mm diameter x 3 mm height cylindrical Teflon molds at 37°C, and allowed to gel for 24 h.
Composite hydrogel swelling behavior was assessed with formulations of varying TGM wt
% and PAMAM molecular weight. Following fabrication, the hydrogels were weighed on a 
balance (n=6) and placed in excess PBS for 24 h at 37°C. Hydrogels were then weighed 
after swelling, frozen at −80°C, lyophilized and reweighed when dry. The initial (q(i)) and 
equilibrium (q(e)) hydrogel swelling ratio were calculated as the difference between the 
swollen and dry mass divided by the dry mass [9].
The effect of varying TGM wt%, GMP loading, and culture condition (n = 6 per group) on 
hydrogel mechanical properties after 28 days was investigated. Mechanical testing on a TA 
Instruments Thermomechanical Analyzer 2940 (TA Instruments, Newcastle, DE) equipped 
with a wide compression probe (diameter of 6 mm) was performed to assess the unconfined 
compressive Young’s modulus of the hydrogels. Samples were first placed onto the 
prewarmed stage, and sample height was measured by the probe. The stage was then re-
equilibrated to 37°C and the sample was compressed at a rate of 0.001 N/min to 0.05 N. The 
unconfined Young’s modulus was determined to be the initial slope of the engineering strain 
versus engineering stress curve.
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2.6 MSC harvest and culture
MSCs were harvested from rat femora and tibiae of 6–8 week old Fisher 344 rats (Charles 
River Laboratories, Wilmington, MA) in accordance to approved protocols by the Rice 
Institutional Animal Care and Use Committee as previously described [10]. The MSCs were 
plated in 75 cm2 tissue culture flasks at 37°C under humidified, 5% CO2 atmosphere and 
cultured in osteogenic media without dexamethasone, which was replaced every 2–3 days.
2.7 MSC encapsulation and in vitro culture
For the in vitro and in vivo MSC encapsulation studies, TGM and PAMAM olymers were 
UV sterilized for 3 h, GMPs were EO sterilized for 12 h, and all polymers were dissolved in 
PBS pH 7.4 as described above. After 6 days of culture, the MSCs were passaged and added 
to the polymer solutions at a final concentration of 15 million cells/mL hydrogel. The 
solutions were manually mixed, pipetted into 8 mm x 2 mm autoclaved Teflon molds on a 
heat block, and allowed to crosslink at 37°C in an incubator for 2.5 h before in vitro culture 
or 24 h before in vivo implantation. The formulations selected for in vitro investigation are 
listed in Table 1. The hydrogels and their acellular controls were placed in 2.5 mL media in 
12-well tissue culture plates and cultured for 0, 7, 14, 21, and 28 days in complete 
osteogenic media containing 10−8 M dexamethasone, a potent stimulator of osteogenesis 
[11]. At each timepoint, the hydrogels were soaked in PBS for 30 min, sliced in half, 
weighed, and processed for Live/Dead confocal imaging (n = 2 halves); DNA Picogreen 
assay, alkaline phosphatase (ALP) activity, and calcium biochemical assay (n = 4 halves 
each); and histological staining (n = 2 halves).
2.8 Live/Dead Confocal Microscopy
The samples designated for Live/Dead confocal microscopy were cut into ~0.5 mm cross 
sectional slices with a hand-held razor blade and incubated for 30 min with calcein AM (2 
μM) and ethidium homodimer-1 (4 μM) in accordance with the Live/Dead viability/
cytotoxicity kit instructions. The slices were then analyzed using a confocal microscope 
(LSM 510 META, Carl Zeiss, Germany) using a 10x objective. Argon and helium–neon 
lasers were used for excitation at 488 and 543 nm, respectively, and emission filters at 505–
526 and 612–644 nm, respectively, were employed.
2.9 Biochemical Assays
Hydrogel halves for biochemical assays were stored in 500 μL of ultrapure water and stored 
at -20°C. Prior to analysis, samples were manually homogenized, passed through three 
freeze-thaw cycles, and probe sonicated for 8 s. Detailed protocols for biochemical assays 
are described elsewhere [12]. Double-stranded DNA correlating with cellularity was 
evaluated using DNA Picogreen assay (Invitrogen, Eugene, OR) in accordance to the 
manufacturer’s protocol. Activity of ALP, an osteogenic marker produced by differentiating 
MSCs, was assessed with colorimetric assay using phosphatase substrate capsules in 
alkaline buffer solution against p-nitrophenol standards. To quantify the calcium content, 
sample aliquots were digested overnight in equal parts 1N acetic acid to form a final 0.5N 
acetic acid solution and then evaluated according to the manufacturer’s instructions. All data 
were normalized to the hydrogel wet mass.
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2.10 Cryosectioning and histological staining
Hydrogels (n = 2 halves) were processed at each timepoint for hematoxylin & eosin (H&E) 
and von Kossa histological staining as previously described [10, 13]. Hydrogels were fixed 
at 37 °C for 24 h in 10% buffe red formalin, dehydrated for 24 h in 70% ethanol, and stored 
in Histo-prep for another 24 h prior to freezing at −20 °C and cryosectioning into 10 μm 
slices. H&E staining for cellular distribution and extracellular matrix deposition was 
performed using Mayer hematoxylin counterstained with eosin-Y (Sigma). Von Kossa, a 
commonly used stain for phosphate deposits in bone tissue engineering studies, was 
performed using a 2% silver nitrate solution incubated under UV for 20 min and unreacted 
silver nitrate was removed using 5% sodium thiosulfate. Sections were imaged with a light 
microscope (Eclipse E600, Nikon).
2.11 Animal surgery, post-operative monitoring and implant harvest
This work was done in accordance with protocols approved by the Rice University 
Institutional Animal Care and Use Committee. The hydrogels listed in Table 2 were 
aseptically fabricated in 8 mm x 2 mm molds as described above and implanted within an 8 
mm rat cranial defect for evaluation at 4 and 12 weeks. The hydrogels were pre-formed to 
ensure consistent size and homogenous fabrication allowing for accurate assessment post-
implantation, especially in regards to hydrogel fragmentation due to GMP incorporation. All 
hydrogel groups were statistically randomized to minimize operative- or animal-related 
error. Using 11–12 week Fischer 344 rats weighing 176–200g (Harlan, Indianapolis, IN), an 
8 mm craniotomy was performed under general anesthesia as previously described [14]. The 
calvarial disk was removed, the hydrogel was implanted, and the periosteum and skin were 
each separately closed. The rats were given a single intraperitoneal injection of saline (1 
mL/100 g/h of anesthesia) and then buprenorphine (0.05 mg/kg) (Patterson Veterinary, 
Devens, MA) at 12, 24, and 36 h after surgery as analgesia, and were monitored post-
operatively for the duration of the study. At the designated timepoints, the animals were 
euthanized, and the implants and surrounding tissue were harvested, fixed, and processed for 
microcomputed tomography and histology analysis as previously described [3, 14].
2.12 Microcomputed tomography (microCT) analysis
MicroCT analysis with a Skyscan 1172 High-Resolution Micro-CT (Aartselaar, Belgium) 
with 10 μm resolution, 0.5 mm aluminum filter, and voltage of 100 kV and current of 100 
μA was used to evaluate bone volume and bony bridging across the defect. Volumetric 
reconstruction and analysis was conducted using Nrecon and CT-analyzer software provided 
by Skyscan. The percent of bone formation, including hydrogel mineralization, within the 
defect was determined by centering a cylindrical volume of interest (VOI) of 8 mm in 
diameter and 2 mm in height at the bottom of the defect. Data are reported as the % 
binarized object volume measured within this VOI within thresholding gray values (70–255) 
with the CT-analysis software [15]. The extent of bony bridging and union within the defect 
were scored according to the grading scale in Supplementary Figure 1 using microCT 
generated maximum intensity projections of the samples. 3D models of each sample were 
also generated to visualize the distribution of mineral deposits within the hydrogel implants.
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2.13 Histological Scoring
After microCT scanning, the samples were sent to the MD Anderson Cancer Center Bone 
Histomorphometry Core Laboratory (Houston, TX) for dehydration and embedding in 
poly(methyl methacrylate). 5 μm coronal cross-sections were taken from the center of the 
defect of each sample and staining was performed with von Kossa, H&E, and Goldner’s 
trichrome. The three histological sections were evaluated via light microscopy and scored 
using histological scoring analysis with three blinded reviewers. The histological evaluation 
was performed along random implant-tissue interfaces within central coronal cross-sections 
to assess: (1) tissue response at the bone-hydrogel interface [16], (2) fibrous capsule 
thickness and quality on the dural and periosteal sides of the implant [17], and (3) extent of 
bony bridging across the defect following the rubrics outlined in Supplementary Figure 1. 
Additionally, the degree of hydrogel fragmentation due to tissue infiltration was scored 
according to previously published literature [13, 18].
2.14 Statistics
The data are presented as mean + standard deviation in triplicate, unless otherwise stated. 
Composite characterization data and biochemical assays were analyzed using a Tukey’s 
post-hoc test. Main effects and interaction analysis of hydrogel swelling were performed 
with JMP v.11 statistics software (SAS Institute, Cary, NC). The microCT and histological 
scoring data were analyzed via one-way analysis of variance followed by the Kruskal-Wallis 
test (p<0.05) for n = 7–8 samples. The microCT bone volume data were for n = 7–8 
samples.
3. Results
3.1 Composite hydrogel fabrication and characterization
Composites hydrogels were successfully created by mixing together TGMs, PAMAMs, and 
pre-swollen GMPs. Incorporation of GMPs did not hinder the secondary chemical 
crosslinking of TGMs and PAMAMs, and a stable hydrogel was formed within the 
previously established period of 2.5 h [4]. A partial factorial design study examining the 
effect of TGM wt% and PAMAM Mn demonstrated that GMP loading did not significantly 
affect initial and equilibrium swelling compared to non-gelatin containing hydrogels 
(Supplementary Figure 2A), and also did not affect the compressive properties even after 
culture in complete osteogenic media containing serum (Supplementary Figure 2B).
3.2 In vitro MSC encapsulation
10 and 20 wt% hydrogels with and without GMPs were able to successfully encapsulate 
primary rat MSCs to form hydrogel-cell constructs. Encapsulating cells in serum-containing 
media did not significantly affect hydrogel gelation, and after 2.5 h, a stable hydrogel was 
formed. Figure 1A shows representative cross sections of 10 wt% hydrogels with and 
without gelatin microparticles using Live/Dead confocal microscopy after culture for 0, 7, 
14, 21, and 28 days. The 20 wt% hydrogels performed similarly and confocal images can be 
seen in Supplementary Figure 3. The 0 d images showed that viable MSCs could be 
encapsulated (as shown by the green stain for live cells) without significant cell death (as 
shown by the red stain for dead cells) and homogenously distributed throughout the 
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hydrogel, which was confirmed with H&E staining (data not shown). Confocal imaging at 
the other timepoints demonstrated that cell viability could be maintained throughout the 
hydrogels over the 28 day culture period, and was higher at the later timepoints when GMPs 
were incorporated.
3.3 Biochemical assays and histology
DNA Picogreen data correlating to cellularity are shown in Figure 1B. DNA content in the 
non-GMP-containing hydrogels significantly decreased over time; however, DNA content in 
the GMP-containing hydrogels was sustained over time since no significant differences were 
observed in the DNA levels from the 7 to 28 day timepoints, and showed significant 
improvements over the non-GMP-containing hydrogel counterparts at the later timepoints.
ALP is an enzyme produced by osteogenically differentiating MSCs. Figure 2 shows the 
ALP activity of the hydrogel-MSC constructs normalized to the DNA content over time. 
Two profiles were observed depending on the incorporation of GMPs. Non-GMP-containing 
hydrogels showed significant increases in the ALP activity over time, peaking at 21 days, 
and then declining. The GMP-containing hydrogels did not show significant changes in their 
ALP activity, with the exception of the 10 wt% hydrogels with GMPs at two timepoints. 
However, when comparing across groups at the later timepoint, the ALP activity of the non-
GMP-containing hydrogels was significantly higher.
Mineralization of the hydrogels was evaluated using a calcium biochemical assay, and 
compared to acellular controls (Figure 3B). In all groups, hydrogels demonstrated significant 
increases in calcium content over time, which was reflected in the darker von Kossa staining 
at 28 days (Figure 3A). 20 wt% hydrogels showed significantly greater calcium content than 
10 wt% hydrogels. GMP-containing hydrogels also showed significantly greater calcium 
content than non-GMP-containing hydrogels. Except for the 20 wt% GMP-containing 
hydrogel with cells, all other groups demonstrated mineralization that was not significantly 
greater than their respective acellular control.
3.4 Animal Care
Three groups of 20 wt% hydrogels were investigated in the rat cranial defect model: 
hydrogels with GMPs only (Gel+GMP), hydrogels with MSCs only (Gel+MSC), and 
hydrogels with GMPs and MSCs (Gel+GMP+MSC). Surgery was performed on 47 rats, of 
which one (Gel+GMP+MSC at 4 weeks) was excluded after harvest since the hydrogel 
dislocated from the defect site post-operatively. All other samples were included in the 
microCT and histological analyses.
3.5 MicroCT analysis
MicroCT was used for nondestructive and quantitative analysis of bony bridging and bone 
volume, as well as visualization of mineral distribution. To evaluate bony bridging, 
maximum intensity projections (MIPs) of each sample were generated from the microCT 
datasets and scored by three blinded reviewers according to a 0–4 scale as seen in 
Supplementary Figure 1. Figure 4A shows representative MIPs from each group at each 
timepoint with their respective scores. The presence of partial bony bridging in most of the 
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samples is reflected in the average microCT score of 2 as seen in Figure 4B. However, only 
the Gel+GMP group demonstrated a significant improvement in bony bridging over the two 
timepoints.
MicroCT was also used to quantify the bone volume within the 8 mm x 2 mm VOI, which 
includes mineralization throughout the hydrogel as well as above and below the implant. 
Figure 4C shows the bone volume data as a % binarized object volume above a critical 
threshold grayscale value of 70. Similar to the microCT bony bridging results, only the Gel
+GMP group demonstrated a significant improvement in bony bridging over the two 
timepoints.
3.6 Histological analysis
Figure 5 shows representative histological sections of the samples from each group and 
timepoint following H&E, von Kossa, and Goldner’s trichrome staining. For all the samples, 
the hydrogel can be observed, although some minor artifacts due to delamination and 
mechanical mismatch during slice can be seen. At both the 4 and 12 week timepoints, the 
samples have a well defined and organized fibrous capsule surrounding much of the implant. 
However, there are cases among all the groups where robust bone growth is observed across 
the dural side of the implant that is in direct contact with the hydrogel. Additionally, 
instances of mineralization within the hydrogel volume and tissue infiltration can be 
observed in many of the samples. This is more clearly seen when juxtaposed with the gross 
implant images and microCT MIPs, as shown with representative samples in Figure 6. 
Figure 6A shows the presence of new mineral on the hydrogel implant using microCT, 
which can be visually observed as an opaque white mass in the translucent implant. Figure 
6B shows a microCT MIP demonstrating the presence of mineralization throughout the 
hydrogel volume that is in direct contact with the surrounding hydrogel and osteoid when 
examined through high magnification von Kossa histological stains.
To quantify the regenerative capacity of the hydrogels, histological scoring according to the 
guides in Supplementary Figure 1 was performed to specifically assess bony bridging, tissue 
response at bone-implant interfaces, fibrous capsule thickness and quality, and hydrogel 
fragmentation. Figure 7A shows the results for scoring of bony bridging in the histological 
sections across the dural side of the hydrogel. The Gel+GMP hydrogels were the only group 
to demonstrate significant differences between the two timepoints. To assess tissue response, 
two independent scoring guides were used for the bone-implant interface and the fibrous 
capsule surrounding the rest of the implant. Figure 7B shows the combined scores for the 
tissue response at the left and right interfaces. The scores for each interface are shown in 
Supplementary Figure 4. The average score for all the groups at both timepoints ranges from 
1–2, suggesting that the bone-implant interface is mainly composed of an unorganized 
fibrous tissue. Only a significant difference between timepoints is observed in the Gel+MSC 
samples due to an improvement in the tissue response on the left side of the implants.
Figure 8 shows the combined scores for the thickness and quality of the fibrous capsule 
surrounding the periosteal and dural sides of the implant (as shown in the diagram in 
Supplementary Figure 1). The breakdown of the scores for the periosteal and dural sides of 
the implant can be seen in Supplementary Figure 5. Representative high magnification 
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images of the fibrous capsule and the respective scores for thickness and quality are shown 
in Supplementary Figure 6. Across all groups, no significant differences are observed 
between the 4 and 12 week timepoints under both scoring systems. Based on the average 
thickness score of ~2, the capsule was about 10–30 layers thick, but fibrous-like and well-
organized, as suggested by an average quality score of ~3.
The average histological scores for hydrogel fragmentation due to tissue infiltration are 
shown in Figure 9. The sections were scored according to the inlaid 0–4 scoring guide in 
Figure 9, and representative sections are shown with respective scores. All samples 
demonstrated some degree of fragmentation, as seen by the average score of ~2, but only the 
GMP-containing hydrogels (Gel+GMP and Gel+GMP+MSC) showed significant 
differences from the 4 to 12 week timepoints. Additionally, only the Gel+GMP+MSC 
hydrogels with both GMPs and MSCs demonstrated significantly greater fragmentation 
from the Gel+MSC group at the 12 week timepoint.
4. Discussion
The objective of this study was to evaluate the osteogenic potential and regenerative 
capacity of an injectable dual-gelling hydrogel system for MSC delivery. We hypothesized 
that the hydrophobicity of the hydrogels and presence of natural material as controlled 
through TGM wt% and GMP loading, respectively, would modulate encapsulated cell 
viability, osteogenic differentiation, and hydrogel mineralization in vitro. Additionally, the 
composite hydrogel constructs with both GMPs and MSCs were hypothesized to enhance 
bone regeneration in a rat cranial defect compared to hydrogels with either GMPs or MSCs 
alone.
Stable hydrogels for the encapsulation of primary rat MSCs were successfully fabricated 
through the dual thermal and chemical gelation of the TGM and PAMAM. For the in vitro 
study, 10 and 20 wt% hydrogels with and without GMPs were examined. GMPs and cells 
were shown to not adversely influence hydrogel gelation, and Live/Dead and DNA 
Picogreen assays demonstrated that viable MSCs could be encapsulated homogenously 
within hydrogels for up to 28 days. Although a decline in cell viability was observed in the 
non-GMP-containing hydrogels, as commonly seen in the literature pertaining to synthetic 
hydrogels [19–22], the incorporation of GMPs improved cell viability at the later timepoints. 
This observation agrees with the literature in which the inclusion of a natural binding site to 
allow for cell attachment can improve cell survival [23]. The effect of gelatin incorporation 
was also observed in the production of ALP, an early osteogenic marker. ALP activity was 
enhanced and peaked at the 21 d timepoint in the non-GMP-containing hydrogels, which 
correlated well with the established profile of MSCs undergoing osteogenesis in vitro [13, 
19]. However, ALP activity for the GMP-containing hydrogels was sustained over time, 
suggesting that the state of cellular attachment was directing MSC behavior [24, 25]. Indeed, 
previous work has established that the cellular interaction specifically with collagenous-
based matrix components promotes osteogenic differentiation and cell survival compared to 
adsorption of other attachment proteins such as vitronectin on synthetic scaffolds [26, 27]. In 
another study, seeding MSCs directly onto GMPs was found to more effectively produce 
aggregates capable of osteogenesis due to increased cell-cell and cell-ECM interaction [28]. 
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Hydrogel mineralization of cellular samples and acellular controls was assessed using a 
calcium biochemical assay. As seen previously, hydrogels demonstrated a hydrophobicity-
dependent mineralization over time [3], with 20 wt% hydrogels showing significantly 
greater calcium content compared to 10 wt% hydrogels with and without cells. However, 
GMP incorporation was also found to be a significant factor, with GMP-containing 
hydrogels demonstrating significantly greater calcium content than their non-GMP-
containing counterparts. Additionally, when MSCs and GMPs were jointly encapsulated, a 
significant difference from the acellular controls was observed at the 28 day timepoint. A 
possible explanation for this effect is that gelatin comprises denatured collagen, which is the 
primary ECM component of mineralized matrix, and assists in mineral nucleation [29, 30]. 
This mechanism has been mimicked in gelatin nanoparticles to nucleate hydroxyapatite 
crystals [31], and thus, provides further evidence by which hydrogel mineralization can be 
promoted without initially using inorganic materials, and highlights another function for 
GMPs in scaffolds beyond controlled release carriers and porogens.
Two concerns associated with the in vitro evaluation include the use of particular media 
supplements and the short culture duration, which may overstate the osteogenic potential of 
the hydrogel system. Thus a longer in vivo study was performed to investigate the actual 
performance of the hydrogels for bone regeneration. For the in vivo evaluation, we chose to 
further examine the 20 wt% hydrogel formulation based on its ability to maintain long-term 
cell viability and enhance hydrogel mineralization. Three groups were examined: hydrogels 
with GMPs only (Gel+GMP), hydrogels with MSCs only (Gel+MSC), and hydrogels with 
GMPs and MSCs (Gel+GMP+MSC). Although no significant differences were observed 
between groups at the 4-week timepoint, microCT scoring of bony bridging and bone 
volume demonstrate that there was some degree of union and bone formation in all the 
groups, which is a departure from previously published results with similar acellular, non-
composite hydrogels in this model [3]. Similarly, no significant differences in the microCT 
data were seen at 12 weeks, but the hydrogels with GMPs only (Gel+GMP) showed 
significant differences between the 4 and 12 week timepoints. While this observation could 
be construed as a minimal effect of the MSCs, another interpretation may be that the 
incorporation and subsequent degradation of the GMPs creates pores that can facilitate 
tissue infiltration and ingrowth, leading to improved bony bridging and volume as seen with 
other porous scaffolds [32, 33] and in contrast to the limited regenerative performance 
previously observed with slower degrading non-GMP-containing hydrogels [3]. Despite this, 
significant bone fill was not observed with microCT, which may be attributed to the lack of 
extensive porosity and sufficient mechanical properties to promote tissue ingrowth. Further 
work and use of other techniques such as x-ray diffraction in addition to microCT may 
provide insight into the type of bone tissue formed and strategies to enhance it.
The joint effect of the MSCs and GMPs is more clearly observed when examining the 
histology for tissue response and integration. The majority of the samples at the 4 and 12 
week timepoints presented a favorable tissue response through a thin organized fibrous 
capsule around the implant and at the bone-implant interface, an established response with 
implantation of biomaterials [34]. However, bony bridging across defect and mineralization 
within the different hydrogel groups was also observed, which directly contacted the 
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surrounding hydrogel and is typically uncharacteristic of synthetic hydrogels in this model 
[35, 36]. Additionally, the presence of osteoid within the center of the hydrogels, especially 
those containing GMPs, demonstrated that the hydrogels were capable of fragmentation 
leading to tissue infiltration and direct bone-implant contact. These results suggest that the 
dual incorporation of MSCs and GMPs can facilitate the osteoconductivity and 
osteoinductivity of synthetic scaffolds for enhanced bone formation and scaffold integration. 
Previous studies required the incorporation of mineral content or osteogenic growth factors 
in order to induce bone tissue infiltration in the rat cranial defect, even when GMPs were 
loaded as a delivery vehicle [16, 32, 35, 36]. In contrast, simple incorporation of GMPs and 
MSCs together in the bulk matrix led to improvements in bone formation and quality in 
vivo, leading to performances similar to that of NiPAAm copolymer macromers containing 
phosphate for specific interaction with alkaline phosphatase [13]. MSCs have been shown to 
have a multitude of paracrine effects, including secretion of factors to recruit host cells, 
which could positively alter the endogenous regenerative process [5]. However, the ability 
to achieve hydrogel fragmentation in vivo via GMP degradation greatly affected the 
underlying tissue response.
5. Conclusion
In this study, the osteogenic potential in vitro and regenerative capacity in vivo of an 
injectable, dual-gelling hydrogel system for MSC delivery was investigated. Hydrogels 
successfully and homogenously encapsulated MSCs without detriment to cell viability or 
hydrogel gelation, and maintained cell survival over 28 days in conjunction with 
incorporated GMPs. Cell-laden composite hydrogels modulated ALP activity in a GMP 
loading-dependent manner and significantly promoted hydrogel mineralization in vitro. In 
vivo evaluation in a rat critical size cranial defect demonstrated the ability of the cell-laden 
composite hydrogels to enable bony bridging across the defect and mineralization 
throughout the hydrogel volume and in direct contact with the surrounding hydrogel. 
Histological analysis showed a favorable tissue response and significant tissue infiltration 
resulting from in vivo fragmentation of the hydrogels, especially those containing GMPs. 
The results of this study suggest that the incorporation of natural material porogens can be 
successfully employed to promote cell viability and hard tissue formation in hydrogel 
environments. Thus, these injectable, dual-gelling hydrogels hold great promise as 
regenerative substrates for stem cell delivery in craniofacial tissue engineering applications.
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Abbreviations
3D Three dimensional
AA Acrylic acid
AIBN Azobisisobutyronitrile
ALP Alkaline phosphatase
COM Complete osteogenic media
DBA Dimethyl-γ-butyrolactone acrylate
ECM Extracellular matrix
FBS Fetal bovine serum
GMA Glycidyl methacrylate
GMP Gelatin microparticle
1H NMR Proton Nuclear Magnetic Spectroscopy
HPLC High Performance Liquid Chromatography
MBA Methylene Bisacrylamide
MicroCT Microcomputed tomography
Mn Number average molecular weight
Mw Weight average molecular weight
MSC Mesenchymal stem cell
NiPAAm N-isopropylacrylamide
PiP Piperazine
PAMAM Polyamidoamine
PBS Phosphate buffered saline
PDI Polydispersity index
TGM Thermogelling macromer
VOI Volume of interest
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Figure 1. 
A) Representative Live/Dead confocal microscopy images of 10 wt% groups with 15 
million cells/mL hydrogel with (bottom row) and without (top row) gelatin microparticle 
(GMP) incorporation and B) DNA content of cell-laden hydrogels after culture in complete 
osteogenic medium for 0, 7, 14, 21, and 28 days. In confocal images, live cells (small 
diameter) and autofluorescing GMPs (large diameter, indicated by white dashed outline) 
stain green, and dead cells stain red. Scale bar in confocal images indicates 100 μm. (*), 
(**), and (#) indicate significant difference from 0 day timepoint, 0 and 7 day timepoints, or 
from non-GMP containing group at the same timepoint, respectively (p<0.05). Error bars 
indicate standard deviation (n=3–4). Confocal images demonstrating 20 wt% hydrogels 
performing similarly can be seen in Supplementary Figure 3.
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Figure 2. 
Alkaline phosphatase activity of 10 and 20 wt% cell-laden hydrogels with and without 
gelatin microparticles (GMPs) after culture in complete osteogenic medium after 0, 7, 14, 
21, and 28 days. (*) indicates significant difference across timepoints in the same group 
(p<0.05). Letters A–C indicate differences across groups at the same timepoint. Bars with 
different letters indicate significant difference (p<0.05). Unmarked bars show no significant 
difference. Error bars indicate standard deviation (n=3–4).
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Figure 3. 
A) Representative von Kossa histological sections at 28 days and B) calcium content of cell-
laden hydrogels (Cell) and acellular controls (Acell) after culture in complete osteogenic 
medium for 0, 7, 14, 21, and 28 days. Von Kossa stains phosphate deposits black-brown. (*) 
and (#) indicate significant differences between timepoints in the same group or from the 
corresponding acellular control at the same timepoint, respectively (p<0.05). Error bars 
indicate standard deviation (n=3–4).
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Figure 4. 
A) Representative maximum intensity projections with the respective scores and B) bony 
bridging score and bone volume as determined by microcomputed tomography (microCT). 
Bony bridging was scored using the guide in Supplementary Table 1. Bone volume was 
quantified within an 8 mm x 2 mm volume of interest. (*) indicates significant difference 
between the 4 and 12 week timepoints (p<0.05). Error bars indicate standard deviation 
(n=7–8).
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Figure 5. 
Representative histological cross sections of hematoxylin & eosin (H&E) (top), von Kossa 
(middle), and Goldner’s trichrome (bottom) stains of hydrogels with GMPs only, MSCs 
only, or both GMPs and MSCs at the 4 and 12 week timepoints. Scale bars below the von 
Kossa stain indicate 1 mm and 8 mm, respectively.
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Figure 6. 
Visualization and distribution of hydrogel mineralization using different techniques. A) 
Microcomputed tomography (microCT) generated image and optical picture of a Gel+MSC 
specimen at 4 weeks demonstrating mineralization at the top of the hydrogel, which can be 
observed grossly as opaque white mass on the translucent hydrogel. B) MicroCT generated 
maximum intensity projection and von Kossa stain of a Gel+GMP+MSC sample at 12 
weeks, demonstrating mineral deposits through the hydrogel volume and in direct contact 
with the surrounding hydrogel. Scale bars in microCT images indicate 1 mm. Scale bars in 
histology cross section and high magnification image indicate 1 mm and 100 μm, 
respectively. H, M, and O in the histology image mean hydrogel, mineral, and osteoid, 
respectively.
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Figure 7. 
Histological scoring of A) bony bridging and B) combined tissue response at the left (L) and 
right (R) bone-implant (total) interface of hydrogels with GMPs only (Gel+GMP), MSCs 
only (Gel+MSC) or both GMPs and MSCs (Gel+GMP+MSC). (*) indicates significant 
difference between the 4 and 12 week timepoints (p<0.05). Error bars indicate standard 
deviation (n=7–8). Average scores for the L and R interfaces can be found in Supplementary 
Figure 4.
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Figure 8. 
Combined histological scores of fibrous capsule thickness and quality at two locations on 
the periosteal (top) and dural (bottom) sides of the hydrogel. Gel+GMP, Gel+MSC, and Gel
+GMP+MSC correspond to hydrogels with GMPs only, hydrogels with MSCs only, or 
hydrogels with both GMPs and MSCs. Error bars indicate standard deviation (n=7–8). 
Breakdown of scores at the top and bottom of the hydrogels can be found in Supplementary 
Figure 5.
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Figure 9. 
Histological scoring of hydrogel fragmentation correlating with tissue infiltration on a 0–4 
scale. Representative histological sections and their respective scores are shown on the right. 
Gel+GMP, Gel+MSC, and Gel+GMP+MSC correspond to hydrogels with gelatin GMPs 
only, hydrogels with MSCs only, or hydrogels with both GMPs and MSCs. (*) and (#) 
indicate significant differences between the 4 and 12 week timepoints or from the Gel+MSC 
group at the same timepoint, respectively (p<0.05). Error bars indicate standard deviation 
(n=7–8).
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Table 1
Study design evaluating the effect of TGM wt% and GMP loading on in vitro MSC encapsulation
Group TGM wt% (mg TGM/100 μL PBS) GMP Loading (mg GMP/100 mg 
hydrogel)
Encapsulation Density (cells/mL 
hydrogel)
1 10 0 1.5×l07
2 20 0 1.5×l07
3 10 20 1.5×l07
4 20 20 1.5×l07
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Table 2
Study design evaluating the effect of GMP and/or MSC encapsulation on in vivo bone regeneration
Group TGM wt% (mg TGM/100 μl PBS) GMP loading (mg GMP/100 mg 
hydrogel)
Encapsulation Density (cells/mL 
hydrogel)
Gel+GMP 20 20 0
Gel+MSC 20 0 1.5×l07
Gel+GMP+MSC 20 20 1.5×l07
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